BART1 Activators
BART1 Activators are a collection of chemicals that influence the activity of BART1 through various mechanisms impacting signaling pathways. Phorbol 12-myristate 13-acetate (PMA), an activator of protein kinase C (PKC), can enhance the phosphorylation state of numerous proteins, potentially including BART1, assuming it is a PKC substrate. Forskolin raises cAMP levels, thereby activating protein kinase A (PKA) which could phosphorylate BART1 to augment its activity. Similarly, ionomycin raises intracellular calcium levels, which could activate calcium-dependent kinases, leading to the phosphorylation and activation of BART1. Epigallocatechin gallate (EGCG), through its kinase inhibition, could de-repress inhibitory phosphorylation events on BART1. Spermine, which affects ionchannels and kinase activity, might stimulate a signaling cascade that results in the activation of BART1.
Sildenafil, by inhibiting phosphodiesterase type 5, maintains elevated levels of cGMP which could activate downstream signaling pathways, resulting in the phosphorylation and subsequent activation of BART1. Staurosporine, although a broad-spectrum kinase inhibitor, could paradoxically facilitate BART1 activation by inhibiting kinases that negatively regulate BART1. LY294002, a PI3K inhibitor, might also lead to BART1 activation by altering downstream signaling involving AKT. U0126 inhibits MEK1/2, thereby dampening the MAPK/ERK pathway, which could shift signaling towards pathways that activate BART1. Trichostatin A (TSA), by inhibiting histone deacetylases, may increase the expression of regulatory proteins that interact with and enhance BART1 activity. Okadaic Acid, by inhibiting protein phosphatases PP1 and PP2A, could increase the phosphorylation level of BART1, assuming it is within their target range. Lastly, Bisindolylmaleimide I's selective inhibition of PKC isoforms might enhance BART1 activity by interrupting negative feedback loops, assuming PKC isoforms regulate BART1's function. Collectively, these diverse chemicals employ distinct biochemical mechanisms to modulate signaling pathways that ultimately lead to the enhanced functional activity of BART1.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is a diterpene produced by the Indian Coleus plant. It activates adenylyl cyclase, increasing intracellular cAMP levels. Elevated cAMP activates PKA, which can then phosphorylate target proteins, enhancing BART1's functional activity if BART1 is influenced by PKA-dependent phosphorylation. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Isobutylmethylxanthine (IBMX) is a non-selective inhibitor of phosphodiesterases, enzymes responsible for the breakdown of cAMP. By preventing cAMP degradation, IBMX indirectly sustains PKA activity, potentially enhancing the functional activity of BART1 through PKA-mediated signaling pathways. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a pyrrolidine antibiotic that acts as a protein synthesis inhibitor. Apart from this, it can activate stress-activated protein kinases (SAPKs) like JNK. If BART1 activity is modulated by stress or JNK-mediated signaling, anisomycin could indirectly enhance BART1 function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 is a selective inhibitor of MEK, which acts upstream of ERK in the MAPK pathway. By inhibiting MEK, PD 98059 could lead to adaptive responses that enhance compensatory pathways, indirectly increasing BART1 activity if BART1 is a part of these compensatory mechanisms. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diester of phorbol and a potent tumor promoter that acts as a PKC activator. By activating PKC, PMA could enhance signaling pathways that modulate BART1 function if BART1 is regulated by PKC-mediated phosphorylation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which can activate calcium-dependent signaling pathways. If BART1 activity is modulated by calcium signaling, the increased intracellular calcium due to ionomycin could enhance BART1 function. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride is known to inhibit glycogen synthase kinase 3 (GSK-3). Inhibition of GSK-3 can lead to the activation of Wnt signaling pathway components, which could indirectly enhance BART1 activity if BART1 is modulated by Wnt pathway intermediates. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that, similar to ionomycin, increases intracellular calcium concentration and activates calcium-dependent signaling pathways. If BART1 function is calcium-dependent, A23187 could enhance BART1 activity. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is a potent inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels of various proteins. If BART1 function relies on phosphorylation status, okadaic acid could indirectly enhance BART1 activity by inhibiting its dephosphorylation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a specific inhibitor of phosphoinositide 3-kinases (PI3K). Inhibition of PI3K can lead to alteration in downstream signaling, potentially enhancing BART1 activity if BART1 is part of the PI3K/Akt pathway. | ||||||